MASIMO
Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive patient monitoring products. It provides a patient monitoring solution that incorporates a monitor or circuit board and sensors, including both proprietary single-patient use and reusable sensors and cables. The company also offers Masimo Signal Extraction Technology, which provides the capabilities of measure-through motion and low perfusion pulse oximetry to address the primary limitations of conv... entional pulse oximetry. In addition, it provides remote-alarm/monitoring solutions and software. The company sells its products to end-users through direct sales force and distributors, as well as to original equipment manufacturers and partners to incorporate into their products. Masimo Corporation was founded in 1989 and is headquartered in Irvine, California.
MASIMO
Industry:
Biotechnology Health Care Manufacturing Medical Device
Founded:
1989-01-01
Address:
Irvine, California, United States
Country:
United States
Website Url:
http://www.masimo.com
Total Employee:
1001+
Status:
Active
Contact:
9492977099
Total Funding:
754.95 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Google Tag Manager Content Delivery Network Font Awesome Domain Not Resolving Apache Mobile Non Scaleable Content
Similar Organizations
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
Bio/Data Corporation
Bio/Data Corporation is a leading manufacturer and distributor of platelet function products.
HOMEOSTASIS LABS
Homeostasis Labs is a United States-based biotechnology company manufacturing homeopathy products.
Norman Biological Technology
Norman Biological Technology is a manufacturer of automated chemiluminescence system.
SomaLogic
SomaLogic is a protein biomarker discovery and clinical diagnostics company, offers SOMAmer technology to improve diagnostic products.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-02-15 | Sound United | Sound United acquired by Masimo | N/A |
| 2020-11-02 | Lidco | Lidco acquired by Masimo | 31.1 M GBP |
| 2020-03-20 | TNI medical | TNI medical acquired by Masimo | N/A |
| 2020-01-14 | NantHealth - Connected Care | NantHealth - Connected Care acquired by Masimo | 47.25 M USD |
| 2012-03-12 | Spire Corporation | Spire Corporation acquired by Masimo | 8.5 M USD |
| 2010-07-13 | SEDLine | SEDLine acquired by Masimo | N/A |
Investors List
Politan Capital Management
Politan Capital Management investment in Post-IPO Equity - Masimo
Robeco
Robeco investment in Post-IPO Equity - Masimo
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Grant - Masimo
Signatures Capital
Signatures Capital investment in Venture Round - Masimo
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2018-01-03 | StartUp Health | Masimo investment in Venture Round - StartUp Health | 19.3 M USD |
| 2010-01-12 | SEDLine | Masimo investment in Venture Round - SEDLine | 3.5 M USD |
Official Site Inspections
http://www.masimo.com Semrush global rank: 787.3 K Semrush visits lastest month: 50.06 K
- Host name: 104.18.36.190
- IP address: 104.18.36.190
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Masimo"
Masimo - Wikipedia
Pulse oximetry uses two light emitting diodes (LEDs), one red and one infrared, to measure the absorption of light and translates that into the percentage of hemoglobin molecules that are bound to oxygen, which is called arterial oxygen saturation (SpO2). Conventional pulse oximetry assumes that arterial blood is the only blood moving (pulsating) in the measurement site. However, during patient motion, the venous blood also moves, which can cause conventional pulse oximetry to u…See details»
Masimo - The Org
Masimo (NASDAQ: MASI) is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a …See details»
About - Masimo
Masimo is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors. We believe that Masimo SET® helps clinicians monitor …See details»
Masimo - Leadership Team - The Org
The Leadership Team at Masimo is responsible for setting the strategic direction and operational execution of the company, ensuring alignment across various functions such as technology …See details»
Masimo - Crunchbase Company Profile & Funding
Masimo also offers the first FDA-authorized device to alert users in the event of an opioid overdose, Opioid Halo™, and wearable devices like the Masimo W1™ advanced health tracking watch. The company sells its products to end-users …See details»
About Masimo
Masimo is the proud recipient of a 2022 Zenith Award, presented by AARC (the American Association of Respiratory Care) Fast Company 2021 Innovation by Design Awards Masimo …See details»
Governance Documents - Masimo
Changes to Code of Business Conduct and Ethics (Effective October 21, 2021) (opens in new window)See details»
Company Profile for Masimo
Jul 12, 2019 Masimo is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, …See details»
Masimo - Governance - Committee Composition
© Masimo. All Rights Reserved. Powered By Q4 Inc. 5.143.9.1 (opens in new window) 5.143.9.1 (opens in new window)See details»
Org Chart Masimo - The Official Board
The organizational chart of Masimo displays its 16 main executives including Michelle Brennan, Micah Young and Bilal Muhsin. Toggle navigation The Official Board. Search. Search. Search …See details»
Contact - Masimo
Masimo Europe Limited - Italian Branch Via Domenico Scarlatti 30 20124 Milano Italy Tel: +39 02 4507 6308 Fax: +39 02 450 76 309 Email: [email protected]. Masimo International All: …See details»
About Masimo | Personal Health - Canada
Experience personalized sound with Masimo Adaptive Acoustic Technology (AAT) About Masimo. About Masimo Find out why clinicians have trusted Masimo for over twenty-five years About …See details»
Masimo - SET Pulse Oximetry
Masimo and the Birth of SET ® Pulse Oximetry. Joe Kiani, Founder and CEO of Masimo, established the company precisely to address the common limitations of pulse oximeters …See details»
Masimo - About Masimo - mymasimo.com
Masimo SafetyNet supports people recovering at home with the same hospital-grade pulse oximetry technology, Masimo Signal Extraction Technology ® (SET ®), that is the primary …See details»
Masimo - Home
Masimo Personal Health. HEOS is our local and cloud computing technology that enables all integrations with music services, voice assistants, third-party and automation companies, …See details»
Masimo Company Profile - Office Locations, Competitors, Revenue …
Oct 29, 2024 Masimo has 5 employees across 24 locations and $2.05 b in annual revenue in FY 2023. See insights on Masimo including office locations, competitors, revenue, financials, …See details»
News & Media - Masimo
Visit marchofdimes.org or nacersano.org for more information. About Masimo. Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide array of …See details»
Masimo - Home
Masimo Adaptive Acoustic Technology™ delivers personalized, lossless sound, creating a unique hearing profile tuned perfectly to your hearing. By measuring each person’s hearing sensitivity …See details»
What Analysts Are Saying About Masimo Stock - Nasdaq
Dec 27, 2024 Net Margin: Masimo's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 1.94%, the company may …See details»
Masimo - Contract Research Organizations Solutions
Clinical Trials Are Changing. In clinical research, recent guidance from the FDA has called for greater commitments to real-world evidence of drug interactions, equitable inclusion, and …See details»